What Trump’s Latest Moves Mean for the Industry
May 27, 2025
Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.
6 min read
Trends & Forecasts
The Next Decade of Cell and Gene Therapies
May 7, 2025
Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.
5 min read
Sitting Down With… The Past: Kowid Ho
April 9, 2025
We dive into the archive of 2022 for insight and inspiration – this time with Kowid Ho
3 min read
Predictions for Pharma’s Future
April 8, 2025
We asked experts about their views of the future of pharma. Process digitization, data, and sustainability are key themes.
4 min read
The Economics of Biosimilars
By Stephanie Vine
April 4, 2025
We ask James Chambers from Tufts Medical Center about the challenges faced by biosimilars in the US
7 min read
The Trump Effect on Cell and Gene: Science versus Shockwaves
April 1, 2025
Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track.
9 min read
The Future of the NIH
By Hernan Bazan
March 27, 2025
Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.
2 min read
The Glycomic Revolution
March 27, 2025
Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D
2 min read
We Need to Talk About CRISPR
March 21, 2025
Neal Baer, editor of a collection of essays on CRISPR, says we must not overlook the dark side of the technology.
4 min read
Looking to Next-Generation Sequencing and Multi Omics Technologies
March 17, 2025
Experts explain why these are two important areas to watch in the near future of pharma R&D.
2 min read
